Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AM281 is a potent and selective central cannabinoid (CB1) receptor antagonist/inverse agonist (Kis = 12 nM and 4,200 nM for CB1 and CB2, respectively).1,2 Structurally, it is an analog of the CB1 inverse agonist rimonabant (Item No. 9000484).2 It has no effect on the vanilloid TRPV1 receptor.3 AM281 has been used to evaluate the potential effects of compounds at CB1.4,5 It has also been used to study the membrane localization and cycling of CB1.6
WARNING This product is not for human or veterinary use.
1. Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand. AAPS Pharmsci. 1(3), 1-7 (1999).
2. Binding of the non-
3. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Br. J. Anaesth. 89(6), 882-887 (2002).
4. The cannabinomimetic arachidonyl-
5. Cannabinoid receptor-
6. Constitutive endocytic cycle of the CB1 cannabinoid receptor. The Journal of Biological Chemisty 279(34), 36013-36021 (2004).